当前位置:首页 / 维持性血液透析患者高钾血症预防与管理的最佳证据总结
论著·系统评价 | 更新时间:2024-02-26
|
维持性血液透析患者高钾血症预防与管理的最佳证据总结
Best evidence summary for the prevention and management of hyperkalemia in patients undergoing maintenance hemodialysis

广西医学 2023第45卷23期 页码:2893-2900

作者机构:冯倩,在读硕士研究生,护士,研究方向为内科护理,慢病管理。

DOI:10.11675/j.issn.0253-4304.2023.23.16

  • 中文简介
  • 英文简介
  • 参考文献

目的 总结维持性血液透析(MHD)患者高钾血症预防与管理的最佳证据。方法 依据“6S”证据金字塔模型,在国内外相关网站和数据库中检索与MHD患者高钾血症预防与管理相关的证据,包括临床决策、临床实践指南、专家共识/专家建议、证据总结与系统评价。评价文献质量后,提取并汇总证据。结果 最终纳入10篇文献,其中3篇临床决策、4篇临床实践指南、3篇专家共识/专家建议。从管理目标与风险评估、饮食管理、血液透析优化、升钾药物管理、降钾药物干预、合理监测6个维度生成25条最佳证据。结论 基于MHD患者高钾血症预防与管理的最佳证据,医护人员可结合患者情况与临床实际情况选取合适的证据制订适宜的防治方案,以降低MHD患者高钾血症的发生率,提高患者的生活质量。

ObjectiveTo summarize the best evidence for the prevention and management of hyperkalemia in patients undergoing maintenance hemodialysis (MHD). MethodsBased on the "6S" evidence pyramid model, evidence related to the prevention and management of hyperkalemia in MHD patients was retrieved from domestic and overseas relevant websites and databases, including clinical decision-making, clinical practice guidelines, expert consensus/recommendations, evidence summary, and systematic reviews. After evaluating quality of the literature, evidence was extracted and summarized. ResultsA total of 10 literature was eventually enrolled, therein there were 3 articles of clinical decision-making, 4 articles of clinical practice guidelines, 3 articles of expert consensus/recommendations. A total of 25 pieces of best evidence were generated from 6 dimensions, including management objectives and risk assessment, diet management, hemodialysis optimization, potassium raising drug management, potassium lowering drug intervention, and reasonable monitoring. ConclusionBased on the best evidence for the prevention and management of hyperkalemia in MHD patients, medical staff can select appropriate evidence and formulate appropriate prevention and treatment regimen in combination with patients′ conditions and clinical actual conditions, so as to decrease the incidence rate of hyperkalemia in MHD patients, and to improve the quality of life in patients.

833

浏览量

161

下载量

0

CSCD

工具集